TY - JOUR
T1 - A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract
AU - Liu, Fang
AU - Moreno, P.
AU - Basit, A.W.
PY - 2010
Y1 - 2010
N2 - Oral pH-responsive systems for drug delivery to the ileo-colonic region of the gastrointestinal tract show poor site specificity. Here, we describe a novel double-coating concept, based on the acrylic polymer EUDRAGIT® S, which provides improved functionality for targeting performance. The coating system comprises an inner layer of partially neutralised EUDRAGIT® S and buffer agent and an outer coat of standard EUDRAGIT® S. Tablets containing prednisolone were coated with double-layer formulations with different inner coat compositions. A conventional single coating was also applied for comparison purposes. Dissolution of the coated tablets was assessed using USP II apparatus in 0.1 M HCl for 2 h followed by pH 7.4 physiological bicarbonate buffer (Krebs buffer), a medium which closely resembles the ionic composition and buffer capacity of the fluid in the distal small intestine. Following acid exposure, drug release from the EUDRAGIT® S single-layer-coated tablets in pH 7.4 Krebs buffer was delayed for 120 min. Release from the double-coated tablets was significantly faster compared to the single-coated tablets and was found to be affected by the pH and buffer capacity of the inner coat. The drug release lag time from the optimised double-coating formulation with an inner coat consisting of 10% KH2PO4 (neutralisation pH of 8.0) was 40 min. The accelerated coat dissolution and subsequent rapid drug release from the double-coating system can potentially overcome the limitations of conventional EUDRAGIT® S coatings for ileo-colonic delivery.
AB - Oral pH-responsive systems for drug delivery to the ileo-colonic region of the gastrointestinal tract show poor site specificity. Here, we describe a novel double-coating concept, based on the acrylic polymer EUDRAGIT® S, which provides improved functionality for targeting performance. The coating system comprises an inner layer of partially neutralised EUDRAGIT® S and buffer agent and an outer coat of standard EUDRAGIT® S. Tablets containing prednisolone were coated with double-layer formulations with different inner coat compositions. A conventional single coating was also applied for comparison purposes. Dissolution of the coated tablets was assessed using USP II apparatus in 0.1 M HCl for 2 h followed by pH 7.4 physiological bicarbonate buffer (Krebs buffer), a medium which closely resembles the ionic composition and buffer capacity of the fluid in the distal small intestine. Following acid exposure, drug release from the EUDRAGIT® S single-layer-coated tablets in pH 7.4 Krebs buffer was delayed for 120 min. Release from the double-coated tablets was significantly faster compared to the single-coated tablets and was found to be affected by the pH and buffer capacity of the inner coat. The drug release lag time from the optimised double-coating formulation with an inner coat consisting of 10% KH2PO4 (neutralisation pH of 8.0) was 40 min. The accelerated coat dissolution and subsequent rapid drug release from the double-coating system can potentially overcome the limitations of conventional EUDRAGIT® S coatings for ileo-colonic delivery.
UR - http://www.scopus.com/inward/record.url?scp=75449087620&partnerID=8YFLogxK
U2 - 10.1016/j.ejpb.2009.11.008
DO - 10.1016/j.ejpb.2009.11.008
M3 - Article
AN - SCOPUS:75449087620
SN - 0939-6411
VL - 74
SP - 311
EP - 315
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
IS - 2
ER -